Phase 3 Pulmonary Aspergillosis Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh300 enrolled1 locationNCT06174922
Recruiting
Phase 3
Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole
Chronic Pulmonary Aspergillosis
Poitiers University Hospital224 enrolled1 locationNCT03656081
Recruiting
Phase 3
A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis
Chronic Pulmonary AspergillosisCPAAspergilloma
Post Graduate Institute of Medical Education and Research, Chandigarh196 enrolled1 locationNCT06447402
Completed
Phase 2Phase 3
Omalizumab for Chronic Allergic Bronchopulmonary Aspergillosis: a randomised, placebo-controlled crossover trial
Allergic Bronchopulmonary Aspergillosis
Jo Douglass14 enrolled1 locationACTRN12613000278730